Access to Health Care

Share

Every American deserves access to quality, affordable health care. From cancer screenings like mammograms and colonoscopies to the latest breakthroughs in treatment, everyone should have access to the care that could prevent cancer and save their life.  In addition, ensuring that low-income working families have access to affordable health insurance is proven to reduce overall health care costs. 

We are working in every state and in Congress to expand health care options and protect existing laws that help patients get true access to the care they need. 

People without health insurance are more likely to be diagnosed with cancer at a late stage, when the disease is harder to treat, more costly and more difficult to survive.

Latest Updates

July 3, 2025
National

Following U.S. House passage of the budget bill containing the most devastating cuts to Medicaid in history and changes to the ACA Marketplace that will make it more expensive and difficult to obtain and keep health insurance, ACS CAN expresses deep disappointment and urges Congress to extend the enhanced ACA tax credits.

July 2, 2025
Maine

ACS CAN Thanks Maine Senators for Voting to Protect Medicaid

July 1, 2025
North Carolina

RALEIGH, N.C. – July 1, 2025 – Today the U.S. Senate passed the budget reconciliation bill H.R. 1, by a vote of 51 to 50. John Broome, North Carolina government relations director with the American Cancer Society Cancer Action Network (ACS CAN) released the following statement: “Congress is making an

June 27, 2025
National

Today, the U.S. Supreme Court issued its ruling in the case of Kennedy v. Braidwood Management.

Access to Health Care Resources

Telehealth visits that enable providers to deliver clinical services from a distance using options like video conferencing and remote monitoring can provide cancer patients and survivors with a convenient means of accessing both cancer care and primary care.

Advances in precision medicine have led to targeted cancer therapies that have improved patient outcomes and quality of life within populations of cancer patients with very specific biomarkers. Testing patients for cancer biomarkers is integral to identify those who may benefit from targeted therapy. Despite the importance of such testing, many cancer patients are not tested for biomarkers. This fact sheet highlights recent advancements in targeted cancer therapies and data from ACS CAN Survivor Views surveys of cancer patients and survivors assessing barriers to biomarker testing.  

ACS CAN responded to the reopening of the Centers for Medicare and Medicaid Services (CMS) coverage decision for NGS testing panels.

  •